$2.47T
Total marketcap
$207.15B
Total volume
BTC 50.02%     ETH 15.67%
Dominance

Oxford Nanopore ONTTF Stock

1.8 USD {{ price }} -0.826901% {{change_pct}}%
Exchange
Other OTC
Market Cap
1.55B USD
LOW - HIGH [24H]
1.77 - 1.82 USD
VOLUME [24H]
2.73K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.19 USD

Oxford Nanopore Price Chart

Oxford Nanopore ONTTF Financial and Trading Overview

Oxford Nanopore stock price 1.8 USD
Previous Close 2.94 USD
Open 2.93 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 2.94 - 2.94 USD
52 Week Range 2.2 - 4.2 USD
Volume 4.59K USD
Avg. Volume 7.77K USD
Market Cap 2.43B USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -0.19 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

ONTTF Valuation Measures

Enterprise Value 2.1B USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 12.228922
Price/Book (mrq) 3.4940476
Enterprise Value/Revenue 10.576
Enterprise Value/EBITDA -25.471

Trading Information

Oxford Nanopore Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -26.25%
S&P500 52-Week Change 20.43%
52 Week High 4.2 USD
52 Week Low 2.2 USD
50-Day Moving Average 2.97 USD
200-Day Moving Average 2.98 USD

ONTTF Share Statistics

Avg. Volume (3 month) 7.77K USD
Avg. Daily Volume (10-Days) 4.05K USD
Shares Outstanding 827.5M
Float 516.24M
Short Ratio N/A
% Held by Insiders 34.19%
% Held by Institutions 41.09%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -45.83%
Operating Margin (ttm) -49.58%
Gross Margin 62.33%
EBITDA Margin -41.52%

Management Effectiveness

Return on Assets (ttm) -7.38%
Return on Equity (ttm) -13.026%

Income Statement

Revenue (ttm) 198.6M USD
Revenue Per Share (ttm) 0.24 USD
Quarterly Revenue Growth (yoy) 2.10%
Gross Profit (ttm) 123.81M USD
EBITDA -82461000 USD
Net Income Avi to Common (ttm) -91025000 USD
Diluted EPS (ttm) -0.13
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 356.78M USD
Total Cash Per Share (mrq) 0.43 USD
Total Debt (mrq) 34.1M USD
Total Debt/Equity (mrq) 4.92 USD
Current Ratio (mrq) 6.222
Book Value Per Share (mrq) 0.84

Cash Flow Statement

Operating Cash Flow (ttm) -49387000 USD
Levered Free Cash Flow (ttm) -36325876 USD

Profile of Oxford Nanopore

Country United States
State N/A
City Oxford
Address Gosling Building
ZIP OX4 4DQ
Phone 44 84 5034 7900
Website https://nanoporetech.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 1009

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells. The company also provides PromethION 2, a self-contained benchtop nanopore sequencer; PromethION 24, which provides single or multiple users with access to terabases of sequencing data; PromethION 48, a sequencing device with high-output flow cells; VolTRAX, an automated library prep for nanopore analyses; and Q-Line, a sequencing for applied applications, as well as products for SAR-Cov-2 testing. Its platform enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.

Q&A For Oxford Nanopore Stock

What is a current ONTTF stock price?

Oxford Nanopore ONTTF stock price today per share is 1.8 USD.

How to purchase Oxford Nanopore stock?

You can buy ONTTF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Oxford Nanopore?

The stock symbol or ticker of Oxford Nanopore is ONTTF.

Which industry does the Oxford Nanopore company belong to?

The Oxford Nanopore industry is Biotechnology.

How many shares does Oxford Nanopore have in circulation?

The max supply of Oxford Nanopore shares is 859.5M.

What is Oxford Nanopore Price to Earnings Ratio (PE Ratio)?

Oxford Nanopore PE Ratio is now.

What was Oxford Nanopore earnings per share over the trailing 12 months (TTM)?

Oxford Nanopore EPS is -0.19 USD over the trailing 12 months.

Which sector does the Oxford Nanopore company belong to?

The Oxford Nanopore sector is Healthcare.